885266-91-1

Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
2-AMINO-4-(1'HYDROXYETHYL)-PYRIDINE is used as a chelating agent for the synthesis of pharmaceuticals and agrochemicals, leveraging its ability to form complexes with metal ions, which can enhance the stability and effectiveness of these compounds.
Used in Organic Synthesis:
As a building block, 2-AMINO-4-(1'HYDROXYETHYL)-PYRIDINE is utilized in the creation of various organic compounds, contributing to the structural diversity and functional properties of synthesized molecules.
Used in Coordination Chemistry:
2-AMINO-4-(1'HYDROXYETHYL)-PYRIDINE is employed as a ligand in coordination chemistry, where it can bind to metal ions to form coordination compounds with potential applications in various fields, including catalysis and materials science.
Used in Catalyst Development for Organic Reactions:
In the realm of catalysis, 2-AMINO-4-(1'HYDROXYETHYL)-PYRIDINE serves as a ligand in the development of catalysts that can facilitate and enhance the efficiency of organic reactions, contributing to advancements in synthetic chemistry and industrial processes.

InChI:InChI=1/C7H10N2O/c1-5(10)6-2-3-9-7(8)4-6/h2-5,10H,1H3,(H2,8,9)

Upstream product

• 6937-03-7 methyl 2-aminoisonicotinate 
• 1312764-33-2 1-(2-hydrazinopyridin-4-yl)ethanol 
• 1245644-98-7 1-(2-chloropyridin-4-yl)ethan-1-ol 
• 42182-25-2 1-(2-amino-4-pyridyl)-1-ethanone 
• 42182-27-4 4-cyanopyridin-2-amine 

Downstream Products

• 1229649-40-4 N-(4-(1-((4-(3-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)ureido)naphthalen-1-yl)oxy)ethyl)pyridin-2-yl)-2-methoxyacetamide 

Relevant academic research and scientific papers

Discovery of Narrow Spectrum Kinase Inhibitors: New Therapeutic Agents for the Treatment of COPD and Steroid-Resistant Asthma

The discovery of a novel series of therapeutic agents that has been designed and optimized for treating chronic obstructive pulmonary disease is reported. The pharmacological strategy was based on the identification of compounds that inhibit a defined subset of kinase enzymes modulating inflammatory processes that would be effective against steroid refractory disease and exhibit a sustained duration of action after inhaled delivery.

Inhibitors of Hemopoietic Cell Kinase (P59-HCK) and Their Use in the Treatment of Influenza Infection

The present invention relates inter alia to the treatment or prevention of influenza virus infection (including subtypes influenza A virus, influenza B virus, avian strain H5N1, A/H1N1, H3N2 and/or pandemic influenza) using compounds which inhibit the act

INHIBITORS OF HEMOPOIETIC CELL KINASE (P59-HCK) AND THEIR USE IN THE TREATMENT OF INFLUENZA INFECTION

The present invention relates inter alia to the treatment or prevention of influenza virus infection (including subtypes influenza A virus, influenza B virus, avian strain H5N1, A/H1N1, H3N2 and/or pandemic influenza) using compounds which inhibit the activity of p59-HCK and to a method of screening for a candidate drug substance intended to prevent or treat influenza virus infection in a subject, said method comprising identifying a test substance capable of inhibiting p59-HCK activity.

AMINO-HETEROARYL DERIVATIVES AS HCN BLOCKERS

The invention relates to amino-heteroaryl derivatives having the general Formula I or a pharmaceutically acceptable salt thereof, to pharmaceutical compositions comprising the same, as well as to the use of these derivatives for the treatment of pain, such as neuropathic pain or inflammatory pain.

2, 7 -NAPHTHYRIDIN- 1 -ONE DERIVATIVES AS SYK KINASE INHIBITORS

Provided herein area novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated Syk kinase activity.